Organoids for drug discovery and personalized medicine

149Citations
Citations of this article
336Readers
Mendeley users who have this article in their library.

Abstract

A wide variety of organs are in a dynamic state, continuously undergoing renewal as a result of constant growth and differentiation. Stem cells are required during these dynamic events for continuous tissue maintenance within the organs. In a steady state of production and loss of cells within these tissues, new cells are constantly formed by differentiation from stem cells. Today, organoids derived from either adult stem cells or pluripotent stem cells can be grown to resemble various organs. As they are similar to their original organs, organoids hold great promise for use in medical research and the development of new treatments. Furthermore, they have already been utilized in the clinic, enabling personalized medicine for lammatory bowel disease. In this review, I provide an update on current organoid technology and summarize the application of organoids in basic research, disease modeling, drug development, personalized treatment, and regenerative medicine.

Cite

CITATION STYLE

APA

Takahashi, T. (2019, January 6). Organoids for drug discovery and personalized medicine. Annual Review of Pharmacology and Toxicology. Annual Reviews Inc. https://doi.org/10.1146/annurev-pharmtox-010818-021108

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free